Want to see ALHC full AI Analyst Report?
ALHC Stock Chart & Stats
$20.98
$0.17(1.45%)
At close: 4:00 PM EST
$20.98
$0.17(1.45%)
Day’s Range― - ―
52-Week Range$11.63 - $23.97
Previous CloseN/A
Volume165.75K
Average Volume (3M)7.12M
Market Cap
$4.92B
Enterprise Value$3.35B
Total Cash (Recent Filing)$1.41B
Total Debt (Recent Filing)$329.97M
Price to Earnings (P/E)241.0
Beta0.70
Next Earnings
Jul 30, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding206,733,830
10 Day Avg. Volume7,351,627
30 Day Avg. Volume7,123,098
Financial Highlights & Ratios
PEG Ratio53.67
Price to Book (P/B)21.81
Price to Sales (P/S)0.99
P/FCF Ratio34.56
Enterprise Value/Market Cap0.68
Enterprise Value/Revenue0.79
Enterprise Value/Gross Profit6.35
Enterprise Value/Ebitda50.39
Forecast
1Y Price Target
$23.29Price Target Upside10.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)0.18
Revenue Forecast (FY)$5.19B
Bulls Say, Bears Say
Bulls Say
Cash GenerationSustained, growing operating and free cash flow provides durable internal funding for network investments, technology (claims automation, AI) and working capital. Strong cash conversion reduces liquidity and refinancing risk and supports execution of scaled MA operations without relying on external financing.
Membership & Revenue ScaleRapid, sustained membership growth expands recurring CMS capitation revenue and spreads fixed SG&A and platform costs. Scale improves bargaining power with providers, enhances data for care management, and strengthens predictable revenue streams central to long-term MA economics.
Balance Sheet DeleveragingMaterial debt reduction drastically lowers financial risk and interest burden, increasing strategic flexibility. A stronger balance sheet supports sustained investment in provider partnerships and technology, and reduces vulnerability to cyclical payment timing or reserve swings common in MA operations.
Bears Say
Thin ProfitabilityVery slim net margins and declining gross margin leave little buffer against utilization or reimbursement shocks. In a capital-intensive MA model, narrow unit economics limit reinvestment capacity and make long-term profitability contingent on sustained medical cost control and continued efficiency gains.
Higher-Acuity Mix & UtilizationDeliberate expansion into higher-acuity cohorts (C‑SNP/LIS SNP) and new markets increases inpatient utilization and medical benefit ratio structurally. If unit economics for these populations or for new PPO products aren’t fully optimized, persistent mix-driven cost pressure can erode margins despite revenue growth.
Policy / Rate UncertaintyCMS rate increases trailing medical cost trends create structural reimbursement pressure for MA plans. Persistent rate-to-cost gaps complicate benefit design and provider contracting, making long-term margin sustainability dependent on either cost reductions or changes in regulatory reimbursement levels.
Alignment Healthcare News
ALHC FAQ
What was Alignment Healthcare, Inc.’s price range in the past 12 months?
Alignment Healthcare, Inc. lowest stock price was $11.63 and its highest was $23.96 in the past 12 months.
What is Alignment Healthcare, Inc.’s market cap?
Alignment Healthcare, Inc.’s market cap is $4.92B.
When is Alignment Healthcare, Inc.’s upcoming earnings report date?
Alignment Healthcare, Inc.’s upcoming earnings report date is Jul 30, 2026 which is in 29 days.
How were Alignment Healthcare, Inc.’s earnings last quarter?
Alignment Healthcare, Inc. released its earnings results on Apr 30, 2026. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.007 by $0.043.
Is Alignment Healthcare, Inc. overvalued?
According to Wall Street analysts Alignment Healthcare, Inc.’s price is currently Undervalued.
Does Alignment Healthcare, Inc. pay dividends?
Alignment Healthcare, Inc. does not currently pay dividends.
What is Alignment Healthcare, Inc.’s EPS estimate?
Alignment Healthcare, Inc.’s EPS estimate is 0.13.
How many shares outstanding does Alignment Healthcare, Inc. have?
Alignment Healthcare, Inc. has 206,733,830 shares outstanding.
What happened to Alignment Healthcare, Inc.’s price movement after its last earnings report?
Alignment Healthcare, Inc. reported an EPS of $0.05 in its last earnings report, beating expectations of $0.007. Following the earnings report the stock price went down -10.115%.
Which hedge fund is a major shareholder of Alignment Healthcare, Inc.?
Currently, no hedge funds are holding shares in ALHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Alignment Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.29 (10.99% Upside)
$23.29 (10.99% Upside)
Blogger Sentiment
Bullish
ALHC Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 149.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $36.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.94%
12-Months-Change
Fundamentals
Return on Equity
11.50%
Trailing 12-Months
Asset Growth
40.86%
Trailing 12-Months
Company Description
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.
ALHC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlights robust top-line growth (membership +31%, revenue +33%), strong margin expansion (adjusted EBITDA up 88%), improved efficiency (SG&A as % of revenue down ~60 bps) and strengthened liquidity, alongside tangible operational progress in automation and AI. The main negatives were a one-time internal workflow error that temporarily increased inpatient admissions and some short-term utilization pressure tied to targeting higher-acuity members, plus industry-level uncertainty from modest CMS rate increases versus underlying health care trend. Management portrayed these issues as diagnosed and remediated or baked into guidance, and raised full-year guidance and tightened ranges, indicating confidence in execution and outlook.View all ALHC earnings summariesALHC Stock 12 Month Forecast
Average Price Target
$23.29
▲(10.99% Upside)
Technical Analysis
Ownership Overview
17.17% Insiders
37.20% Mutual Funds
29.21% Other Institutional Investors
1.61% Public Companies and
Individual Investors